Asthma

MarketReports.com | Pharmaceuticals & Healthcare | Diseases and Treatment |  Asthma

Asthma – Pipeline Review, H1 2012 Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: 27-Feb-2012 Format: PDF Pages: 288 Publisher: Global Markets Direct More...

Asthma - Pipeline Review, Q1 2011 Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: 28-Feb-2011 Format: PDF Pages: 195 Publisher: Global Markets Direct More...

Asthma - Pipeline Assessment and Market Forecasts to 2017 Price Single User $2,000.00 Site License $4,000.00 Global Site License $6,000.00 Publication Date: Dec-2010 Format: PDF Pages: 66 Publisher: GlobalData More...

Asthma/COPD in Australia Market Forecast Price: $5,700.00 (€4,492.42) ($6,840.00 (€5,390.90) Including VAT at 20%) Publication Date: 20-May-2010 Please click here for more information or to purchase this report at our partner store In-depth overview and 10 year outlook for currently marketed and pipeline asthma/COPD products in Australia, examining both clinical and commercial factors driving product differentiation and uptake.

Asthma/COPD Market Forecast Price: $15,200.00 (€11,979.77) ($18,240.00 (€14,375.73) Including VAT at 20%) Publication Date: 29-Sep-2010 Please click here for more information or to purchase this report at our partner store Asthma and COPD market forecast, taking into account recent advances and setbacks in the pipeline, as well as trends in marketed products and movements by generics companies across the seven major markets.

Asthma - Pipeline Review, Q4 2010 Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: Dec-2010 Format: PDF Pages: 186 Publisher: Global Markets Direct More...

Asthma/COPD in Australia Market Forecast Price: $5,700.00 (€4,492.42) ($6,840.00 (€5,390.90) Including VAT at 20%) Publication Date: 20-May-2010 Please click here for more information or to purchase this report at our partner store In-depth overview and 10 year outlook for currently marketed and pipeline asthma/COPD products in Australia, examining both clinical and commercial factors driving product differentiation and uptake.

Commercial Insight: Asthma/COPD in Australia Price: $5,700.00 (€4,492.42) ($6,840.00 (€5,390.90) Including VAT at 20%) Publication Date: 20-May-2010 Please click here for more information or to purchase this report at our partner store In-depth overview and 10 year outlook for currently marketed and pipeline asthma/COPD products in Australia, examining both clinical and commercial factors driving product differentiation and uptake.

MarketReports.com | Pharmaceuticals & Healthcare | Diseases and Treatment |  Asthma

© 2012 MarketReports.com  Contact Us | Privacy Policy | Terms & Conds